Ignite Creation Date:
2025-12-25 @ 12:37 AM
Ignite Modification Date:
2026-02-28 @ 10:38 PM
Study NCT ID:
NCT05644067
Status:
COMPLETED
Last Update Posted:
2024-04-15
First Post:
2022-10-27
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Assessment of the Malaria Vaccine Candidate SumayaVac-1 in Healthy Adults Aged 18-45 Years Living in a Malaria Endemic Country
Sponsor:
Swiss Tropical & Public Health Institute
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-08-25
Start Date Type:
ACTUAL
Primary Completion Date:
2024-04-02
Primary Completion Date Type:
ACTUAL
Completion Date:
2024-04-02
Completion Date Type:
ACTUAL
First Submit Date:
2022-10-27
First Submit QC Date:
None
Study First Post Date:
2022-12-09
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-04-10
Last Update Post Date:
2024-04-15
Last Update Post Date Type:
ACTUAL